Difference between revisions of "Drug toxicity"

From Libre Pathology
Jump to navigation Jump to search
Line 3: Line 3:
This article covers a few of the distinctive histomorphologic pattern and links to other articles that deal with specific organ systems.
This article covers a few of the distinctive histomorphologic pattern and links to other articles that deal with specific organ systems.


=Liver drug toxicity=
*[[Drug-induced liver disease]].
=Luminal gastrointestinal pathology=
==Sodium polystyrene sulfonate==
==Sodium polystyrene sulfonate==
:[[AKA]] ''Kayexalate'' (trade name).
:[[AKA]] ''Kayexalate'' (trade name).
Line 20: Line 24:
{{Main|Proton pump inhibitor effect}}
{{Main|Proton pump inhibitor effect}}


==See also==
=See also=
*[[Drug-induced liver disease]].
*[[Minocycline associated thyroid pigmentation]].
*[[Minocycline associated thyroid pigmentation]].
*[[Spironolactone bodies]].
*[[Spironolactone bodies]].


==References==
=References=
{{Reflist|1}}
{{Reflist|1}}


[[Category:Stuff]]
[[Category:Stuff]]

Revision as of 15:15, 5 September 2014

Drug toxicity, also drug reaction, in pathology is often a diagnosis of exclusion. Few drugs leave a distinctive histomorphologic pattern.

This article covers a few of the distinctive histomorphologic pattern and links to other articles that deal with specific organ systems.

Liver drug toxicity

Luminal gastrointestinal pathology

Sodium polystyrene sulfonate

AKA Kayexalate (trade name).

General

  • Used to treat hyperkalemia.

Microscopic

Features:[1]

Image

Proton pump inhibitor

See also

References